SAIC // Science Applications International Corporation
FA <GO> NASDAQ RQD COCKPIT → CIK 0001571123 ↗| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-30 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-02-02 |
|---|---|---|---|
| Revenue (Total Sales) | $7.26B | $7.48B | $7.44B |
| YoY Revenue Growth % | -2.9% | +0.5% | — |
| Gross Profit | $872.0M | $892.0M | — |
| Gross Margin % | 12.0% | 11.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $521.0M | $563.0M | $741.0M |
| Operating Margin % | 7.2% | 7.5% | 10.0% |
| Net Income (GAAP) | $358.0M | $362.0M | $477.0M |
| EBITDA (Normalized) | $546.6M | $591.8M | $1.01B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $609.0M | $494.0M | $396.0M |
| Capital Expenditures (CapEx) | $32.0M | $36.0M | $335.0M |
| Free Cash Flow (FCF) | $577.0M | $458.0M | $61.0M |
| FCF Margin % | 7.9% | 6.1% | 0.8% |
| Return on Invested Capital (ROIC %) | 10.9% | 13.0% | 10.8% |
| Cash & Short-Term Equivalents | $182.0M | $56.0M | — |
| Total Debt (Short + Long Term) | $2.47B | $1.91B | $2.09B |
| Total Stockholders' Equity | $1.50B | $1.58B | $4.29B |